Gabrielle N. Bulliard Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
unknown
Research Areas
Biography and Research Information
OverviewAI-generated summary
Gabrielle N. Bulliard's research focuses on the precision and efficacy of RNA-guided DNA integration, particularly in the context of gene therapy. Her work investigates the complex genomic and transcriptomic changes that occur following AAV-CRISPR therapy, with recent publications exploring these effects in high-expressing muscle loci. Bulliard collaborates with researchers from the University of Arkansas at Little Rock, including Christopher E. Nelson, Made Harumi Padmaswari, and Shilpi Agrawal, on shared publications. Her research network also includes Kevin A. Murach from the University of Arkansas at Fayetteville. Bulliard has contributed three publications to the scientific literature, with a total of four citations and an h-index of 2, indicating recent and ongoing activity in her field.
Metrics
- h-index: 2
- Publications: 3
- Citations: 5
Selected Publications
-
Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy (2025)
-
Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci (2024)
-
Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci (2024)
Collaboration Network
Top Collaborators
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
- Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy
Similar Researchers
Based on overlapping research topics